Britain grants first licence for badger cull
(PhysOrg.com) -- The currently available tuberculosis vaccine BCG is over 90 years old and its effectiveness is declining. An increasing number of mycobacterial strains are emerging, against which the ...
A new discovery may explain why a tuberculosis vaccine is not as effective for some people as anticipated, and potentially explains why other vaccines do not work as well for some as they do for others. In a research report ...
Seattle scientists have developed a tuberculosis vaccine that may boost the effectiveness of the only existing vaccine, extending immunity against the disease.
At an international gathering of TB vaccine researchers in Tallinn today, the Aeras Global TB Vaccine Foundation announced it will initiate a clinical trial of an investigational live recombinant tuberculosis vaccine to be ...
Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell ...
A booster shot appears to improve tuberculosis (TB) resistance in previously vaccinated adults, according to new research in South Africa.
(AP) -- The Bill and Melinda Gates Foundation will donate $10 billion over the next decade to research new vaccines and bring them to the world's poorest countries, the Microsoft co-founder and his wife said ...
(AP) -- Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working ...
As a result of dominant media coverage of new epidemic threats such as swine influenza, other infection risks receive less public attention than they deserve.
(AP) -- The World Health Organization says a study has shown that babies with HIV could die if given a standard tuberculosis vaccine.
A team of Vanderbilt University Medical Center investigators has cracked one of clinical medicine's enduring mysteries - what happened to the tuberculosis vaccine. The once-effective vaccine no longer prevents the bacterial ...
(PhysOrg.com) -- The world’s leading candidate for a tuberculosis vaccine, developed at the University of Oxford, is to enter Phase IIb proof-of-concept clinical trials, making it the first TB candidate ...
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report scientists at The University ...